Eli Lilly (LLY) has secured a second FDA approval for its oral SERD Inluriyo in under a year, this time in combination with its CDK4/6 inhibitor Verzenio. The regimen is now approved
MoreA federal appeals court has dealt a significant blow to prediction market operator Kalshi, finding its sports event contracts amount to illegal gambling under federal tribal law. On September 16, 2026, a
MoreThe U.S. Court of Appeals for the Second Circuit has amended a recent ruling, bringing significant clarity to Title VII religious accommodation cases across the circuit. The amended decision, issued on September
MoreIn one of the most extraordinary episodes in American legal history, a 19th-century lawyer accidentally shot himself during a courtroom demonstration and died the following day. The lawyer was defending a man
MoreFilling a Stocks and Shares ISA with high-yield dividend shares is a popular strategy for investors seeking to build long-term passive income streams. The approach can be highly rewarding, but it carries
MoreAPi Group Corporation (APG) has attracted renewed investor attention following significant backing from Truist, shifting how the market views the stock. Truist’s involvement signals a degree of institutional confidence in APi Group
MoreCharles River Laboratories International (CRL) has long been a dominant force in preclinical drug development services, supplying pharmaceutical and biotech clients worldwide. The company operates across a broad range of services, including
MoreAs artificial intelligence infrastructure expands at pace, the insurance risks surrounding global data centres are growing increasingly complex and harder to manage. Large lawsuits involving data centres more than tripled from four
MoreEurope’s CHMP Backs Dozen New Medicines Including Novo Nordisk (NVO) And AstraZeneca (AZN) Offerings
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended 12 new medicines for approval at its September 2026 meeting. The CHMP also backed extensions of indication for 11 existing
MoreFor nearly two decades, the Ninth Circuit’s “server test” stood as the only appellate standard for judging whether embedded online content infringes copyright. That changed when the Fifth Circuit weighed in on
More
